AllianceBernstein
IMNM icon

AllianceBernstein’s Immunome IMNM Stock Holding History

AllianceBernstein’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Sell
133,500
-29,950
-18% -$641K ﹤0.01% 1833
2026
Q1 		$3.51M Buy
163,450
+70,460
+76% +$1.57M ﹤0.01% 1708
2025
Q4 		$2M Buy
92,990
+37,730
+68% +$662K ﹤0.01% 2004
2025
Q3 		$647K Hold
55,260
– – ﹤0.01% 2546
2025
Q2 		$514K Buy
55,260
+6,750
+14% +$55.3K ﹤0.01% 2628
2025
Q1 		$326K Sell
48,510
-5,280
-10% -$50.7K ﹤0.01% 2733
2024
Q4 		$571K Hold
53,790
– – ﹤0.01% 2577
2024
Q3 		$786K Hold
53,790
– – ﹤0.01% 2431
2024
Q2 		$651K Buy
+53,790
New +$841K ﹤0.01% 2519

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

AllianceBernstein's IMNM Position: Q2 2026 in Review

AllianceBernstein reduced its Immunome (IMNM) stake by 18% in Q2 2026, selling an estimated $641K and leaving 133,500 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

AllianceBernstein first reported a position in IMNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.51M in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • AllianceBernstein held 133,500 shares of Immunome worth $2.92M as of Q2 2026.
  • AllianceBernstein sold 29,950 Immunome shares in Q2 2026, an estimated $641K.
  • Immunome made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1833 holding.
  • AllianceBernstein first reported a position in Immunome in Q2 2024 and has held it in 9 quarters since.
  • AllianceBernstein's Immunome position peaked at $3.51M in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.